Anaphylaxis
Sublingual epinephrine film moving forward, NDA anticipated by early next year
Aquestive Therapeutics expects to finish its final supportive study of its Anaphylm sublingual epinephrine film for the treatment of anaphylaxis by the end of 2024.
Venom immunotherapy achieves maintenance doses after three up-dosing sessions
A three-session rush venom immunotherapy protocol was safe and effective with nearly all patients achieving maintenance dosing with few systemic reactions, according to a study published in Annals of Allergy, Asthma & Immunology.
Tool stratifies reaction severity among patients with fish allergy
The validated food allergy severity score was useful in classifying the severity of reactions among patients with allergies to various fish, according to a letter published in Annals of Allergy, Asthma & Immunology.
Q&A: Company seeks to expand neffy FDA approval to more pediatric patients
ARS Pharmaceuticals announced its submission of a supplemental new drug application to the FDA for neffy 1 mg for the treatment of type 1 allergic reactions in children who weigh between 33 lb and 66 lb.
Food allergy prevalence doubled in Japan from 2010 to 2019
The prevalence of food allergy surged between 2010 and 2019 in Japan, increasing 1.7 times among children aged 6 years and younger, according to a study in Pediatric Allergy and Immunology.
Top in allergy/asthma: Pharma vs. farms; young people unlikely to inform peers of allergy
In a Healio Expert Submission, Douglas H. Jones, MD, FAAAAI, FACAAI, discussed currently available food allergy treatments and some that are in development.
GA2FA 2024 inspires attendees to think ‘inside the box’ to advance food allergy treatment
The Global Allergy and Asthma Excellence Network, or GA2LEN, will host its biannual global meeting from Sept. 5 to 7.
Top news of August: FDA neffy approval, women’s asthma health, APA-AAI conference, more
Healio has compiled August’s most-read news in asthma and allergy.
Q&A: Xolair ‘Accidents Happen’ ad campaign aims to help food allergy management
Despite daily vigilance in managing food allergies, everything does not always go according to plan.
EURneffy adrenaline nasal spray approved for use in the EU
The European Commission has approved EURneffy for the emergency treatment of allergic reactions, according to a press release by ARS Pharmaceuticals, producer of the drug.